Review ArticleReview Article
Open Access
WNT Signaling in Cardiac and Vascular Disease
Sébastien Foulquier, Evangelos P. Daskalopoulos, Gentian Lluri, Kevin C. M. Hermans, Arjun Deb and W. Matthijs Blankesteijn
Martin C. Michel, ASSOCIATE EDITOR
Pharmacological Reviews January 2018, 70 (1) 68-141; DOI: https://doi.org/10.1124/pr.117.013896
Sébastien Foulquier
Department of Pharmacology and Toxicology, Cardiovascular Research Institute, Maastricht University, Maastricht, The Netherlands (S.F., K.C.M.H., W.M.B.); Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium (E.P.D.); Department of Medicine, Division of Cardiology, David Geffen School of Medicine (G.L., A.D.); and Department of Molecular Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, California (A.D.)
Evangelos P. Daskalopoulos
Department of Pharmacology and Toxicology, Cardiovascular Research Institute, Maastricht University, Maastricht, The Netherlands (S.F., K.C.M.H., W.M.B.); Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium (E.P.D.); Department of Medicine, Division of Cardiology, David Geffen School of Medicine (G.L., A.D.); and Department of Molecular Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, California (A.D.)
Gentian Lluri
Department of Pharmacology and Toxicology, Cardiovascular Research Institute, Maastricht University, Maastricht, The Netherlands (S.F., K.C.M.H., W.M.B.); Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium (E.P.D.); Department of Medicine, Division of Cardiology, David Geffen School of Medicine (G.L., A.D.); and Department of Molecular Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, California (A.D.)
Kevin C. M. Hermans
Department of Pharmacology and Toxicology, Cardiovascular Research Institute, Maastricht University, Maastricht, The Netherlands (S.F., K.C.M.H., W.M.B.); Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium (E.P.D.); Department of Medicine, Division of Cardiology, David Geffen School of Medicine (G.L., A.D.); and Department of Molecular Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, California (A.D.)
Arjun Deb
Department of Pharmacology and Toxicology, Cardiovascular Research Institute, Maastricht University, Maastricht, The Netherlands (S.F., K.C.M.H., W.M.B.); Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium (E.P.D.); Department of Medicine, Division of Cardiology, David Geffen School of Medicine (G.L., A.D.); and Department of Molecular Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, California (A.D.)
W. Matthijs Blankesteijn
Department of Pharmacology and Toxicology, Cardiovascular Research Institute, Maastricht University, Maastricht, The Netherlands (S.F., K.C.M.H., W.M.B.); Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain, Brussels, Belgium (E.P.D.); Department of Medicine, Division of Cardiology, David Geffen School of Medicine (G.L., A.D.); and Department of Molecular Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, California (A.D.)
Martin C. Michel
Roles: ASSOCIATE EDITOR

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Review ArticleReview Article
WNT Signaling in Cardiovascular Disease
Sébastien Foulquier, Evangelos P. Daskalopoulos, Gentian Lluri, Kevin C. M. Hermans, Arjun Deb and W. Matthijs Blankesteijn
Pharmacological Reviews January 1, 2018, 70 (1) 68-141; DOI: https://doi.org/10.1124/pr.117.013896
Jump to section
- Article
- Abstract
- I. Introduction
- II. The History of WNT Signaling
- III. Components of the Receptor Complex
- IV. Regulation of WNT Signaling
- V. Signal Transduction
- VI. WNT Signaling in Cardiac and Vascular Development
- VII. WNT Signaling in Vascular Disease
- VIII. WNT Signaling in Cardiac Disease
- IX. WNT Signaling in Stem Cells
- X. Crosstalk between WNT Signaling and Other Signal Transduction Pathways
- XI. Therapeutic Interventions
- XII. Future Perspectives
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement